Q97832652

motion by Thomas Nihlén et al. 2008

Q97832652 is …
instance of (P31):
committee group motionQ97695005

External links are
P953full work available at URLhttp://data.riksdagen.se/dokument/GW02So253
http://data.riksdagen.se/dokumentstatus/GW02So253
P8433Swedish Riksdag document IDGW02So253

P1001applies to jurisdictionSwedenQ34
P50authorBodil ValeroQ4942281
Gunvor G. EricsonQ4946932
Jan LindholmQ5956750
Peter RådbergQ6086370
Thomas NihlénQ6156728
Christopher ÖdmannQ54396872
P6216copyright statuspublic domainQ19652
P407language of work or nameSwedishQ9027
P1031legal citation of this textMot. 2008/09:So253
P7727legislative committeeCommittee on Health and WelfareQ10672943
P921main subjectmedicationQ12140
Swedish Medical Products AgencyQ1879124
P6104maintained by WikiProjectProject Riksdagen's documentsQ114364300
P179part of the seriesmotions of the 2008-2009 legislative session of the RiksdagQ97769826
P577publication date2008-09-30
P1476titleAnslagsfinansiering av Läkemedelsverket

Reverse relations

Q98410267Q98410267has immediate causeP1478

Search more.